FDA Inspection 1110774 — BrainStorm Cell Therapeutics, Inc

BrainStorm Cell Therapeutics, Inc — FEI 3015810303

The FDA completed an inspection of BrainStorm Cell Therapeutics, Inc on Nov 5, 2019 in Hackensack, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 5, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Hackensack, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.